Compounds > niacinamide

niacinamide and gossypol

niacinamide has been researched along with gossypol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benz, CC; Hollander, C; Keniry, MA1
Cárcamo, JG; Castro, M; Concha, II; Ojeda, L; Ojeda, P; Ortega, M; Pérez, A; Rauch, MC; Reyes, AM; Rivas, CI; Sánchez, C; Valenzuela, X; Vera, JC1
Dai, X; He, F; Lian, J; Ni, Z; Smith, AR; Su, C; Xu, L1

Other Studies

4 other study(ies) available for niacinamide and gossypol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study.
    Biochemical and biophysical research communications, 1989, Oct-31, Volume: 164, Issue:2

    Topics: 6-Aminonicotinamide; Breast Neoplasms; Cell Line; Female; Gossypol; Humans; Magnetic Resonance Spectroscopy; Mitochondria; Niacinamide; Nucleotides; Phosphates; Phospholipids; Phosphorus; Sugar Phosphates

1989
Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.
    American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:1

    Topics: 3-O-Methylglucose; Animals; Antigens, CD; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cytochalasin B; Deoxyglucose; Dose-Response Relationship, Drug; Erythrocytes; Glucose; Glucose Transporter Type 1; Gossypol; HL-60 Cells; Humans; Kinetics; Models, Biological; Niacinamide; Receptor, Insulin; Spectrometry, Fluorescence; Transfection

2009
Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:2

    Topics: Androgens; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; bcl-2 Homologous Antagonist-Killer Protein; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Gossypol; Humans; Male; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyridines; Sorafenib; Time Factors; Xenograft Model Antitumor Assays

2012